Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

What is IVF?

Course / What is IVF?

Summary of The IVF Process

Introduction
In Vitro Fertilization (IVF) is a multi-step assisted reproductive technology (ART) designed to facilitate conception outside the human body. A standard IVF cycle typically spans 3 to 6 weeks, from initial ovarian suppression to embryo transfer. The process is meticulously controlled and monitored to optimize the chances of a successful pregnancy.

The IVF Protocol: A Step-by-Step Medical Breakdown

  1. Ovarian Stimulation (Approximately 8-12 Days)
  • Protocol: The patient undergoes a course of injectable gonadotropins (FSH and/or LH analogs) to stimulate the ovaries to develop multiple ovarian follicles. This is a significant deviation from the natural cycle, which typically produces a single dominant follicle.
  • Monitoring: Response to stimulation is closely tracked through serial transvaginal ultrasounds and serum estradiol level measurements. This allows for real-time medication adjustments to optimize follicular growth while minimizing the risk of Ovarian Hyperstimulation Syndrome (OHSS).
  1. Final Oocyte Maturation & Trigger Shot
  • Protocol: Once follicular maturation is confirmed via ultrasound (leading follicles typically reaching 18-20mm), a final “trigger” injection of hCG or a GnRH agonist is administered.
  • Purpose: This injection mimics the natural LH surge, inducing the final stage of oocyte (egg) maturation within the follicles. The egg retrieval procedure is scheduled for precisely 36 hours post-trigger.
  1. Oocyte Retrieval (Day 0)
  • Procedure: A minor surgical procedure performed under intravenous sedation or anesthesia. Using transvaginal ultrasound guidance, a physician aspirates follicular fluid from each ovary via a thin needle.
  • Laboratory Hand-off: The collected fluid is immediately transferred to the embryology laboratory, where the oocytes are isolated, identified, and placed in a specialized culture medium.
  1. Fertilization & Embryo Culture (Days 1-6)
  • Fertilization: On the day of retrieval, oocytes are fertilized using one of two primary methods:
    • Conventional Insemination: Oocytes are incubated with a prepared sample of motile sperm.
    • Intracytoplasmic Sperm Injection (ICSI): A single sperm is directly injected into each mature oocyte. This is standard for severe male factor infertility or prior IVF fertilization failure.
  • Embryo Development: Fertilized eggs (now zygotes) are cultured in incubators that carefully control temperature, gas concentration, and pH. Development is assessed daily:
    • Day 1: Check for fertilization (2-pronuclear stage).
    • Days 2-3: Cleavage stage embryo development.
    • Days 5-6: Blastocyst formation. Blastocysts are graded on the expansion of the blastocoel cavity, and the quality of the inner cell mass (ICM) and trophectoderm (TE).
  1. Embryo Transfer
  • Timing: Transfer typically occurs at the blastocyst stage (Day 5/6) as it allows for better embryo selection and is more physiologically synchronous with the uterus.
  • Procedure: The highest-quality embryo is loaded into a soft, thin catheter. Under ultrasound guidance, the physician passes the catheter through the cervix and deposits the embryo into the uterine cavity. This is a painless procedure that does not require anesthesia.
  1. Luteal Phase Support & The Two-Week Wait
  • Hormonal Support: Following the retrieval and transfer, the patient begins progesterone supplementation (vaginal, injectable, or oral). This is critical for preparing and maintaining the endometrial lining to support embryo implantation.
  • Pregnancy Test: A quantitative serum beta-hCG test is performed 9-14 days after the embryo transfer to confirm pregnancy.

Why do IVF? Who does it help?

Introduction
IVF is a foundational treatment in reproductive medicine, indicated for a wide range of infertility diagnoses. It is often pursued when less invasive treatments are ineffective, impractical, or have a low probability of success.

Primary Medical Indications for IVF:

  • Tubal Factor Infertility: Bilateral tubal occlusion or significant tubal damage that cannot be surgically repaired. IVF bypasses the fallopian tubes entirely.
  • Severe Male Factor Infertility: Characterized by significant oligospermia (low count), asthenospermia (poor motility), teratospermia (poor morphology), or azoospermia requiring surgical sperm retrieval. ICSI is routinely used in these cases.
  • Diminished Ovarian Reserve (DOR): A reduction in the quantity and quality of a woman’s oocytes, often related to advanced maternal age. IVF aims to maximize the potential of the remaining oocyte cohort.
  • Endometriosis: Particularly in stages III/IV where pelvic anatomy is distorted or when other treatments have failed.
  • Unexplained Infertility: After a full diagnostic workup reveals no abnormalities, IVF can both serve as a treatment and a diagnostic tool, potentially revealing issues with fertilization or embryo development.
  • Genetic Disorders: For couples at risk of transmitting a known genetic abnormality to their offspring, IVF can be paired with Preimplantation Genetic Testing for Monogenic disorders (PGT-M) to select unaffected embryos.
  • Fertility Preservation: For patients facing gonadotoxic medical treatments (e.g., chemotherapy) or those electing to delay childbearing (elective oocyte cryopreservation).

Success Rates: How Often Does IVF Work?

Introduction
IVF success rates are a critical metric, but they must be interpreted with an understanding of the influencing variables. The most relevant statistic is the live birth rate per initiated cycle or per embryo transfer.

Key Determinants of IVF Success:

  1. Female Age: The most significant prognostic factor. Oocyte quality and euploidy (chromosomally normal) rates decline progressively with age.
  2. Ovarian Reserve: Assessed via markers like Antral Follicle Count (AFC) and Anti-Müllerian Hormone (AMH).
  3. Sperm Quality: While ICSI can overcome many sperm issues, the underlying genetic quality of the sperm remains a factor.
  4. Embryo Status: The transfer of a euploid embryo, identified via PGT-A (Preimplantation Genetic Testing for Aneuploidy), significantly increases the chance of implantation and live birth while reducing the risk of miscarriage.
  5. Reproductive History: A prior successful pregnancy is a positive prognostic indicator.
  6. Uterine Receptivity: A normal uterine cavity is essential for implantation.

Representative Success Rate Data (Based on U.S. National Averages*)

Age of Female Partner

Live Birth Rate Per Egg Retrieval

Live Birth Rate Per Single Embryo Transfer (with PGT-A)

Under 35

~55%

~65%

35-37

~40%

~50%

38-40

~26%

~35%

41-42

~13%

~20%

Over 42

~4%

~5%

**Note: Emphasize that these are generalized figures. Specific success rates for Surrogacy4all’s partnered clinics can be provided during a consultation.*

IVF Compared To Other Fertility Treatments

Introduction
IVF exists within a hierarchy of fertility treatments. The selection of the most appropriate treatment is based on the underlying diagnosis, patient age, treatment history, and the risk-benefit profile of each option.

Comparative Analysis of Common Fertility Treatments

Treatment

Mechanism of Action

Typical Candidates

Advantages

Limitations

Ovulation Induction (OI) with Timed Intercourse

Uses oral agents (e.g., Letrozole, Clomiphene) to stimulate monofollicular development.

Anovulatory women (e.g., PCOS).

Low cost, minimal monitoring, non-invasive.

Does not address tubal, male, or severe uterine factors. Low per-cycle efficacy.

Intrauterine Insemination (IUI)

Washed sperm is placed directly into the uterine cavity around the time of ovulation.

Unexplained infertility, mild male factor, cervical factor.

More targeted than timed intercourse, minimally invasive, lower cost than IVF.

Lower success rates per cycle than IVF. Requires at least one patent fallopian tube.

In Vitro Fertilization (IVF)

Fertilization and early embryo development occur in the laboratory.

All major infertility diagnoses, genetic carriers, fertility preservation.

Highest efficacy per cycle. Bypasses tubal factors. Allows for genetic testing of embryos (PGT).

Highest cost. Most invasive treatment. Requires a significant time commitment and carries risks like OHSS.

Strategic Treatment Selection
The transition from IUI to IVF is typically recommended after 3-4 failed IUI cycles, or immediately in cases of severe tubal factor, severe male factor, or advanced maternal age where the time-sensitive nature of the diagnosis warrants the most effective treatment.